Exponent (EXPO) Cash & Equivalents (2016 - 2026)
Exponent filings provide 17 years of Cash & Equivalents readings, the most recent being $221.9 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 14.28% to $221.9 million in Q1 2026 year-over-year; TTM through Jan 2026 was $221.9 million, a 14.28% decrease, with the full-year FY2026 number at $221.9 million, down 14.28% from a year prior.
- Cash & Equivalents hit $221.9 million in Q1 2026 for Exponent, up from $207.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $258.9 million in Q1 2025 to a low of $125.6 million in Q1 2023.
- Median Cash & Equivalents over the past 5 years was $195.2 million (2023), compared with a mean of $190.3 million.
- Biggest five-year swings in Cash & Equivalents: crashed 45.76% in 2022 and later soared 60.25% in 2024.
- Exponent's Cash & Equivalents stood at $161.5 million in 2022, then rose by 15.91% to $187.2 million in 2023, then increased by 17.4% to $219.7 million in 2024, then dropped by 5.61% to $207.4 million in 2025, then rose by 7.02% to $221.9 million in 2026.
- The last three reported values for Cash & Equivalents were $221.9 million (Q1 2026), $207.4 million (Q4 2025), and $231.8 million (Q3 2025) per Business Quant data.